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A B S T R A C T
We describe a case of a 54-year-old patient with rheumatic heart valve disease who was treated with
double valve replacement (both aortic and mitral) twice. Two months after the second operation she
developed a severe mitral paravalvular leakage (PVL) leading to cardiogenic shock for which she was
hospitalized in the intensive care unit. Multiple weaning efforts proved to be unsuccessful because of
persistent hemodynamic instability caused by the severe PVL. Since re-redo cardiac surgery would have
meant an unacceptable high peri-operative risk it was decided in the heart team to close the PVL by a
transcatheter technique. This was done successfully and led to a spectacular hemodynamic
improvement. Just 24 h after closure of the PVL she could be discharged from the intensive care unit
and the day after the procedure she came walking into the echocardiography laboratory for an
echocardiographic evaluation. This case demonstrates not only the feasibility of transcatheter closure of
a PVL but also that this can be a true life-saving act.
<Learning objective: This case emphasizes that refractory heart failure can be a hard indication for
closure of a PVL given the fast and complete clinical recovery after closure of the defect. Furthermore, it
demonstrates the feasibility and the efﬁcacy of transcatheter PVL closure, even when multiple devices
have to be used to close the leak properly avoiding the risks inherent to redo cardiac surgery.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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A paravalvular leak (PVL) is the consequence of an incomplete
sealing between the sewing ring and the valvular annulus. For mitral
valve prostheses, its estimated incidence is about 7–17%. Although
most PVLs are asymptomatic, 1–5% of patients exhibit serious
clinical consequences, which may consist of hemolytic anemia,
infective endocarditis, or congestive heart failure as in our patient
[1]. Currently, the gold standard treatment is redo cardiac surgery
involving either repair of the leak or re-replacement of the valve.
The current case was deemed to be too high risk for redo
surgery by our heart team, and she was treated with a
transcatheter technique. Three approaches can be used: retrograde
transapical, antegrade transseptal, or retrograde aortic. Based on
the two largest case series, technical success ranges from 77% to* Corresponding author at: Department of Cardiology, St. Antonius Hospital,
Koekoekslaan 1, 3435 Nieuwegein, The Netherlands. Tel.: +31 30 6099111;
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1878-5409/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights86% with a clinical success rate of almost 90% and a major adverse
event rate of less than 10% at 30 days after the procedure [2,3].
Consequently, transcatheter PVL closure might be an appropriate
alternative for redo surgery in patients deemed at too high risk.
Case report
A 54-year-old female patient of north-African origin had a
mechanical aortic (Sorin Carbomedics Top Hat1 21 mm; Sorin,
Milan, Italy) and mitral (Sorin Bicarbon1 25 mm) valve implanted
because of rheumatic heart valve disease 10 years before the
current presentation. Because of dysfunction of the mechanical
mitral valve prosthesis due to excessive pannus formation, she
underwent redo mitral (Edwards Perimount1 29 mm; Edwards,
Irvine, CA, USA) and aortic (Sorin Mitroﬂow1 23 mm) valve
replacement (the latter was functioning properly but was removed
to be able to carry out the redo mitral valve replacement safely).
Both procedures were carried out in another hospital. Initially
there was an uneventful postoperative recovery and she went
home clinically well. Two months afterwards she was hospitalized
because of cardiogenic shock with pulmonary edema secondary to reserved.
Fig. 3.
Three-dimensional transesophageal echocardiography (left atrial view
with color ﬂow) after closure showing only a trivial residual regurgitant
jet between the two vascular plugs. MV, mitral valve; P1, plug 1; P2,
plug 2; arrowhead, regurgitant jet.
Fig. 1.
Three-dimensional transesophageal echocardiography (left atrial view
with color ﬂow) before closure showing massive paravalvular
regurgitation on the posterolateral side of the mitral valve
bioprosthesis. MV, mitral valve; arrowheads, regurgitant jet.
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showed a large defect on the posterolateral side of the mitral
valve prosthesis causing severe PVL (Fig. 1). There was no
signiﬁcant valvular mitral regurgitation, a normal functioning
aortic bioprosthesis and a preserved left ventricular ejection
fraction.
The patient was transferred to the cardiac intensive care unit
of our hospital where she was mechanically ventilated maintaining
a high need of vasopressors, inotropics, and loop diuretics
despite the implantation of an intra-aortic balloon pump. Multiple
weaning efforts were unsuccessful. Given the high risk of
re-redo cardiac surgery (EuroSCORE II: 47%), the heart team decided
to treat her by means of a transapical, transcatheter technique to
close the PVL, held responsible for the current therapy-resistant
pulmonary edema.
This procedure was done under general anesthesia, starting
with a small left anterolateral thoracotomy to expose the left
ventricular apex. A purse string suture with pledges was placed,
together with a 9-French sheath. The defect was easily crossed
with a hydrophilic guidewire and two AmplatzerTM vascular plugs
III were implanted (14 and 5 mm – AGA Medical Corporation,
Plymouth, MN, USA) which resulted in an almost complete closure
of the PVL, leaving only a small regurgitant jet between the two
plugs (Figs. 2 and 3). During the hours following the procedure a
spectacular hemodynamic improvement ensued which permittedFig. 2.
Three-dimensional transesophageal echocardiography (left atrial view)
after successful positioning of the two vascular plugs. MV, mitral valve;
P1, plug 1; P2, plug 2.a rapid weaning from the inotropics, vasopressors, diuretics, and
ultimately from mechanical ventilatory support. The next day she
could even walk to the echocardiography laboratory for a
postprocedure evaluation.
Discussion
In this case, we performed a retrograde technique via
transapical approach to close a mitral PVL. In the literature
however, the transfemoral approach with or without an arterio-
venous loop is mostly described [2–5], although transapical
transcatheter PVL closure has increased in popularity [6]. In our
experience, the transapical approach offers a more direct
manipulation of the wires resulting in a more controlled
positioning and release of the plug. Furthermore, multiple guide-
wires may be positioned through the PVL(s) to release the plugs in
a serial manner, without the difﬁculty to pass a residual PVL again
and risking migration and/or embolization. When using one
catheter, the previous plug has to be released before implanting
the subsequent plug as was performed in the current case. When
using more than one catheter, multiple plugs can be released
simultaneously decreasing the risk of migration and enabling
repositioning in case of malpositioning or inadequate closure.
Although a number of unsuccessful procedures have been
described [7–9], this case report emphasizes that severely
symptomatic refractory heart failure can be a hard indication
for closure of a PVL given the fast and complete clinical recovery
after closure of the defect. Furthermore it demonstrates the
feasibility and the efﬁcacy of transcatheter PVL closure, even when
multiple devices have to be used to close the leak properly avoiding
the risks inherent to redo cardiac surgery.
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